According to Monopar Therapeutics's latest financial reports the company's current EPS (TTM) is -$0.77. In 2022 the company made an earnings per share (EPS) of -$0.83 a decrease over its 2021 EPS that were of -$0.74.
Year | EPS | Change |
---|---|---|
2023 (TTM) | -$0.77 | -7.23% |
2022 | -$0.83 | 12.16% |
2021 | -$0.74 | 27.59% |
2020 | -$0.58 | 43.71% |
2019 | -$0.40 | 33.52% |
2018 | -$0.30 | -80.97% |
2017 | -$1.59 |
Company | EPS | EPS differencediff. | Country |
---|---|---|---|
ORIC Pharmaceuticals
ORIC | -$2.18 | 183.12% | ๐บ๐ธ USA |